✦ LIBER ✦

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder

✍ Scribed by Mark H. Pollack; Ulla Lepola; Hannu Koponen; Naomi M. Simon; John J. Worthington; Gerard Emilien; Evan Tzanis; Eliseo Salinas; Timothy Whitaker; Bo Gao

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 239 KB
Volume: 24
Category: Article
ISSN: 1091-4269
DOI: 10.1002/da.20218

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of Venlafaxine ER in patients w

Efficacy of Venlafaxine ER in patients with social anxiety disorder: a double-blind, placebo-controlled, parallel-group comparison with paroxetine

✍ Christer Allgulander; Richard Mangano; Jun Zhang; Alv A. Dahl; Ulla Lepola; Inge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

## Abstract This study evaluated the anxiolytic efficacy, safety and tolerability of a flexible dose of venlafaxine extended release (ER) compared with placebo and paroxetine in the short‐term treatment of generalized social anxiety disorder (SAD). Adult outpatients with generalized SAD (__n__ = 43

A double-blind comparison of the efficac

A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia

✍ Cornelius L. E. Katona; Brian N. Hunter; Julia Bray 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

Objectives. To compare the ecacy of paroxetine and imipramine prospectively in patients with coexisting depression and dementia. Methods. An 8-week, double-blind, parallel group trial comparing paroxetine 20±40 mg/day with imipramine 50±100 mg/day in 198 patients aged 60 years or over with a Montgo

Escitalopram in the treatment of general

Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1

Double-blind, placebo-controlled trial t

Double-blind, placebo-controlled trial to assess the efficacy and tolerability of mepartricin in the treatment of BPH

✍ Denis, Louis; Pagano, Francesco; Nonis, Atanasio; Robertson, Chris; Romano, Paol 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

BACKGROUND. Mepartricin, a semisynthetic polyene derivative with a favorable effect on urethro-prostatic function, was clinically evaluated, adopting the diagnostic and research criteria recommended by the First International Consultation on BPH. METHODS. A multicenter, randomized, double-blind, par

Double-blind, placebo-controlled study t

Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

✍ Francesca Mancini; Roberta Zangaglia; Silvano Cristina; Maria Grazia Sommaruga; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 1 views

## Abstract Drooling is a frequent symptom in Parkinson's disease (PD), occurring in almost 75% of all patients. Although it is now well known that drooling in PD is the result of swallowing difficulties rather than excessive saliva production, few treatments have been developed to reduce it. Clini

Efficacy and tolerability of escitalopra

Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study

✍ Malcolm Lader; Karina Stender; Vera Bürger; Rico Nil 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 1 views